Search - tctmd.com

Displaying 321 - 340 of 746

Sort: Relevancy | Date

News Daily News

ROOBY-FS: 10-Year Data Affirm On-Pump CABG as Default Strategy

February 18, 2022

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

February 11, 2022

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

News Conference News ISC 2022

Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT

February 09, 2022

RCTs in Cardiogenic Shock: Easier Said Than Done!

Presentation THT 2022

RCTs in Cardiogenic Shock: Easier Said Than Done!

Presenter: Manreet Kanwar

February 02, 2022

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

News Daily News

USPSTF: Data Around Screening for AF in Asymptomatic Adults Still Lacking

January 25, 2022

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

News Daily News

Differing Advice for Infective Endocarditis Surgery Stems From Evidence Gaps

January 25, 2022

News Industry News

IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly

January 22, 2022

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

News Daily News

DOACs Should Be Standard to Prevent VTE Recurrence in Cancer: Meta-analysis

January 20, 2022

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

News Features

Pricey Inclisiran Is Rolling Out: a ‘Buy-and-Bill’ Model May Smooth Its Path

Michael O'Riordan

January 17, 2022

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

News Daily News

Shorter Anticoagulation an Option for Young Patients With Provoked VTE

January 11, 2022

Episode 136: Two DCBs vs POBA in Coronary In-Stent Restenosis

Podcast TCTMD Talking Points

Two DCBs vs POBA in Coronary In-Stent Restenosis

January 05, 2022

January 2022 News Roundup

News Opinion CV Team Dispatch

January 2022 News Roundup

January 01, 2022

TCTMD’s Top 10 Most Popular Stories for December 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for December 2021

December 29, 2021

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

News Daily News

Apixaban Appears Safer, More Effective Than Rivaroxaban in Medicare Study

December 27, 2021

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

News Features

Cath Lab Teams Find Enduring Lessons in COVID-19’s Unending Reign

December 20, 2021

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

News Features

As COVID-19 Drags on, the Cardiology Fallout May Haunt for Years

December 16, 2021

Discharge Safe as Early as a Day After Primary PCI for STEMI

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

December 15, 2021

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

December 13, 2021

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

News Features

Home School: Clinical Trials Went Virtual in COVID-19—Are They Here to Stay?

December 09, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.